Provided by Tiger Trade Technology Pte. Ltd.

Provident

23.32
+0.21000.91%
Pre-market: 23.570.2532+1.09%04:04 EDT
Volume:628.93K
Turnover:14.58M
Market Cap:3.05B
PE:9.73
High:23.33
Open:23.09
Low:22.86
Close:23.11
52wk High:25.49
52wk Low:17.69
Shares:130.62M
Float Shares:126.13M
Volume Ratio:0.92
T/O Rate:0.50%
Dividend:0.96
Dividend Rate:4.12%
EPS(TTM):2.40
EPS(LYR):2.23
ROE:11.14%
ROA:1.25%
PB:1.05
PE(LYR):10.45

Loading ...

Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy

GlobeNewswire
·
Yesterday

BRE Commissions Pilot Plant; Co-Funding Secured for Stage II Hydromet Pilot Plant

GlobeNewswire
·
Sep 08

Provident Financial Director Shara Thomas Disposes of 56,166 Common Shares Worth $1.67 Million

Reuters
·
Sep 02

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 31

American Rare Earths' Letter to Shareholders

GlobeNewswire
·
Aug 31

Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 31

Press Release: Akeso 2026 Interim Results: Strong Commercialization Momentum; Io2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's

Dow Jones
·
Aug 28

Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project

GlobeNewswire
·
Aug 28

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 27

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

GlobeNewswire
·
Aug 27

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

GlobeNewswire
·
Aug 25

Provident Financial Completes USD 175 Million Subordinated Notes Offering

Reuters
·
Aug 25

Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

Dow Jones
·
Aug 24

Pilbara Gold extends Mt York mineralisation as PFS drilling reaches halfway mark

TIPRANKS
·
Aug 24

Provident Financial Prices USD 175 Million Subordinated Notes Offering

Reuters
·
Aug 21

Provident Financial Services - Proceeds to Repay $150 Mln Notes Due 2031 and $20 Mln Notes Due 2033

THOMSON REUTERS
·
Aug 21

Provident Financial Services, Inc. Announces Pricing of Subordinated Notes Offering

THOMSON REUTERS
·
Aug 21

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

GlobeNewswire
·
Aug 20

Provident Financial EVP, CRBO Vito Giannola Sells 20,000 Shares for $487,200

Reuters
·
Aug 19

Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP

GlobeNewswire
·
Aug 19